Sorafenib, a novel, oral multi-kinase inhibitor, targets on serine/threonine and receptor tyrosine kinases of the tumor cells and vasculature; blocks the signal transconduction and inhibits tumor growth.

 
  • 摘要索拉非尼是首個(gè)口服多激酶抑制藥,靶向作用于腫瘤細胞和腫瘤血管上的絲氨酸和(或)蘇氨酸及受體酪氨酸激酶,阻斷信號傳導,抑制腫瘤生長(cháng)。
今日熱詞
目錄 附錄 查詞歷史
国内精品美女A∨在线播放xuan